Empirical modeling of T cell activation predicts interplay of host cytokines and bacterial indole

Adoptive transfer of anti‐inflammatory FOXP3+ Tregs has gained attention as a new therapeutic strategy for auto‐inflammatory disorders such as Inflammatory Bowel Disease. The isolated cells are conditioned in vitro to obtain a sufficient number of anti‐inflammatory FOXP3+ Tregs that can be reintroduced into the patient to potentially reduce the pathologic inflammatory response. Previous evidence suggests that microbiota metabolites can potentially condition cells during the in vitro expansion/differentiation step. However, the number of combinations of cytokines and metabolites that can be varied is large, preventing a purely experimental investigation which would determine optimal cell therapeutic outcomes. To address this problem, a combined experimental and modeling approached is investigated here: an artificial neural network model was trained to predict the steady‐state T cell population phenotype after differentiation with a variety of host cytokines and the microbial metabolite indole. This artificial neural network model was able to both reliably predict the phenotype of these T cell populations and also uncover unexpected conditions for optimal Treg differentiation that were subsequently verified experimentally. Biotechnol. Bioeng. 2017;114: 2660–2667. © 2017 Wiley Periodicals, Inc.

[1]  S. Kang,et al.  Short chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway , 2014, Mucosal Immunology.

[2]  Kyongbum Lee,et al.  Microbiome-Derived Tryptophan Metabolites and Their Aryl Hydrocarbon Receptor-Dependent Agonist and Antagonist Activities , 2014, Molecular Pharmacology.

[3]  A. Liston,et al.  Regulatory T Cells , 2011, Methods in Molecular Biology.

[4]  D. Hafler,et al.  FOXP3+ regulatory T cells in the human immune system , 2010, Nature Reviews Immunology.

[5]  H. Vogel,et al.  Quantitative metabolomic profiling of serum and urine in DSS-induced ulcerative colitis of mice by (1)H NMR spectroscopy. , 2010, Journal of proteome research.

[6]  Lin Bin FOXP3~+ regulatory T cells , 2010 .

[7]  D. Cua,et al.  Th17 cell development: from the cradle to the grave , 2013, Immunological reviews.

[8]  R. D. Hatton,et al.  The Th17 family: flexibility follows function , 2013, Immunological reviews.

[9]  George Cybenko,et al.  Approximation by superpositions of a sigmoidal function , 1989, Math. Control. Signals Syst..

[10]  M. Grisham,et al.  Gut‐associated lymphoid tissue, T cell trafficking, and chronic intestinal inflammation , 2010, Annals of the New York Academy of Sciences.

[11]  Lennart Ljung,et al.  System Identification: Theory for the User , 1987 .

[12]  F. Powrie,et al.  The interleukin‐23 axis in intestinal inflammation , 2008, Immunological reviews.

[13]  T. Chatila,et al.  A Central Role for Induced Regulatory T Cells in Tolerance Induction in Experimental Colitis1 , 2009, The Journal of Immunology.

[14]  Aristides G. Eliopoulos,et al.  The gut microbiota in mouse models of inflammatory bowel disease , 2014, Front. Cell. Infect. Microbiol..

[15]  W. Garrett,et al.  Gut microbiota, metabolites and host immunity , 2016, Nature Reviews Immunology.

[16]  F. Powrie,et al.  CD4+ T-cell subsets in intestinal inflammation , 2013, Immunological reviews.

[17]  K. Tanaka,et al.  Effect of intestinal microbiota on the induction of regulatory CD25+ CD4+ T cells , 2008, Clinical and experimental immunology.

[18]  S. Rutz,et al.  IL‐22, not simply a Th17 cytokine , 2013, Immunological reviews.

[19]  A. Rudensky,et al.  Metabolites produced by commensal bacteria promote peripheral regulatory T cell generation , 2013, Nature.

[20]  M. Tomita,et al.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells , 2013, Nature.

[21]  Wendell A. Lim,et al.  Cell-Based Therapeutics: The Next Pillar of Medicine , 2013, Science Translational Medicine.

[22]  K. Honda,et al.  Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species , 2011, Science.

[23]  B. Stockinger,et al.  Differential Influences of the Aryl Hydrocarbon Receptor on Th17 Mediated Responses in vitro and in vivo , 2013, PloS one.

[24]  H. Akaike A new look at the statistical model identification , 1974 .

[25]  D. Vignali,et al.  How regulatory T cells work , 2008, Nature Reviews Immunology.

[26]  M. Levings,et al.  Regulatory T‐cell therapy for inflammatory bowel disease: more questions than answers , 2012, Immunology.

[27]  A. Jayaraman,et al.  The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation , 2009, Proceedings of the National Academy of Sciences.

[28]  M. Neurath,et al.  Transforming growth factor β induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis , 2005, Gut.

[29]  V. Jordan SERMs: meeting the promise of multifunctional medicines. , 2007, Journal of the National Cancer Institute.

[30]  F. Powrie,et al.  Dendritic cells in intestinal immune regulation , 2008, Nature Reviews Immunology.

[31]  E. Zuccato,et al.  Role of bile acids and metabolic activity of colonic bacteria in increased risk of colon cancer after cholecystectomy , 1993, Digestive Diseases and Sciences.

[32]  F. Powrie,et al.  Interleukin-23 Drives Intestinal Inflammation through Direct Activity on T Cells , 2010, Immunity.

[33]  Jay K Kolls,et al.  The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin. , 2013, Annual review of pathology.

[34]  D. Artis,et al.  Intestinal bacteria and the regulation of immune cell homeostasis. , 2010, Annual review of immunology.

[35]  Sang-Uk Seo,et al.  Role of the gut microbiota in immunity and inflammatory disease , 2013, Nature Reviews Immunology.

[36]  A. Yoshimura,et al.  In Vitro Th Differentiation Protocol. , 2016, Methods in molecular biology.

[37]  T. Nomura,et al.  Regulatory T Cells and Immune Tolerance , 2008, Cell.

[38]  Toshifumi Hibi,et al.  Novel, Objective, Multivariate Biomarkers Composed of Plasma Amino Acid Profiles for the Diagnosis and Assessment of Inflammatory Bowel Disease , 2012, PloS one.

[39]  C. Baecher-Allan,et al.  Human regulatory T cells and their role in autoimmune disease , 2006, Immunological reviews.

[40]  Madhav V. Marathe,et al.  Systems Modeling of Molecular Mechanisms Controlling Cytokine-driven CD4+ T Cell Differentiation and Phenotype Plasticity , 2013, PLoS Comput. Biol..

[41]  S. Barry,et al.  Foxp3+ Regulatory T Cells, Th17 Effector Cells, and Cytokine Environment in Inflammatory Bowel Disease , 2009, Journal of Clinical Immunology.

[42]  J. Stroehlein,et al.  Fecal skatole and indole and breath methane and hydrogen in patients with large bowel polyps or cancer , 1985, Journal of Cancer Research and Clinical Oncology.